[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339400-105":59,"doc-detail-339400-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","modulation-of-epithelialmesenchymal-transition-is-a-possible-underlying-mechanism-for-inducing-chemoresistance-in-mia-paca-2-cells-against-gemcitabine-and-paclitaxel","Modulation of Epithelial–Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel","","This study explores molecular mechanisms that drive acquired chemoresistance to gemcitabine and paclitaxel in patients with pancreatic carcinoma by comparing parent MIA PaCa-2 cells with GEM- and PTX-resistant derivatives. Two- and three-dimensional cultures were assessed using spheroid growth behavior, mitochondrial and glycolytic metabolic profiling with a Seahorse bioanalyzer, and RNA sequencing. Bioinformatics identified EMT-related upstream regulators and altered genes, supporting EMT modulation as a key mechanism underlying chemoresistance in these cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/modulation-of-epithelialmesenchymal-transition-is-a-possible-underlying-mechanism-for-inducing-chemoresistance-in-mia-paca-2-cells-against-gemcitabine-and-paclitaxel/339400/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/modulation-of-epithelialmesenchymal-transition-is-a-possible-underlying-mechanism-for-inducing-chemoresistance-in-mia-paca-2-cells-against-gemcitabine-and-paclitaxel/339400.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What cell models were used to study gemcitabine and paclitaxel resistance?","Question",{"text":112,"@type":113},"Parent MIA PaCa-2 cells were compared with GEM-resistant (MIA PaCa-2-GR) and PTX-resistant (MIA PaCa-2-PR) cell lines, evaluated in both 2D and 3D cultures.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were drug resistance-related changes assessed in the study?",{"text":117,"@type":113},"The work evaluated 3D spheroid formation, cellular metabolism (mitochondrial and glycolytic functions) using a Seahorse bioanalyzer, and gene expression changes via RNA sequencing with bioinformatic pathway analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biological process is proposed as a key mechanism for chemoresistance?",{"text":121,"@type":113},"The results suggest that modulations of cancerous epithelial–mesenchymal transition (EMT) may be key molecular mechanisms responsible for inducing chemoresistance against gemcitabine or paclitaxel.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339400,1790126081,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","biomedicines  \nArticle  \nModulation of Epithelial–Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel  \nHajime Nakamura 1, Megumi Watanabe 2, Kohichi Takada 1, Tatsuya Sato 3,4, Fumihito Hikage 2, Araya Umetsu 2, Joji Muramatsu 1, Masato Furuhashi 3 and Hiroshi Ohguro 2, *  \nCitation: Nakamura, H.; Watanabe, M.; Takada, K.; Sato, T.; Hikage, F.; Umetsu, A.; Muramatsu, J.; Furuhashi, M.; Ohguro, H. Modulation of Epithelial–Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel. Biomedicines 2024, 12, 1011 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biomedicines12051011  \nAcademic Editor: Francesco Ciccarese  \nReceived: 26 March 2024  \nRevised: 23 April 2024  \nAccepted: 28 April 2024  \nPublished: 3 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Departments of Medical Oncology, School of Medicine, Sapporo Medical University, S1W17, Chuo-ku, Sapporo 060-8556, Japan; [nakamurahajime27@sapmed.ac.jp](nakamurahajime27@sapmed.ac.jp) (H.N.); [ktakada@sapmed.ac.jp](ktakada@sapmed.ac.jp) (K.T.); [sapsupsap@gmail.com](sapsupsap@gmail.com) (J.M.)  \n2 Departments of Ophthalmology, School of Medicine, Sapporo Medical University, S1W17, Chuo-ku, Sapporo 060-8556, Japan; [watanabe@sapmed.ac.jp](watanabe@sapmed.ac.jp) (M.W.); [fuhika@gmail.com](fuhika@gmail.com) (F.H.); [araya.umetsu@sapmed.ac.jp](araya.umetsu@sapmed.ac.jp) (A.U.)  \n3 Departments of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, S1W17, Chuo-ku, Sapporo 060-8556, Japan; [satatsu.bear@gmail.com](satatsu.bear@gmail.com) (T.S.); [furuhasi@sapmed.ac.jp](furuhasi@sapmed.ac.jp) (M.F.)  \n4 Departments of Cellular Physiology and Signal Transduction, Sapporo Medical University, S1W17, Chuo-ku, Sapporo 060-8556, Japan  \n* Correspondence: [ooguro@sapmed.ac.jp](ooguro@sapmed.ac.jp); Tel.: +81-11-611-2111  \nAbstract: To elucidate the currently unknown molecular mechanisms responsible for the similarity and difference during the acquirement of resistance against gemcitabine (GEM) and paclitaxel (PTX) inpatients with pancreatic carcinoma, we examined two-dimensional (2D) and three-dimensional (3D) cultures of parent MIA PaCa-2 cells (MIA PaCa-2-PA) and their GEM resistance cell line (MIA PaCa-2-GR) and PTX resistance (MIA PaCa-2-PR) . Using these cells, we examined 3D spheroid configurationsand cellular metabolism, including mitochondrial and glycolytic functions, with a Seahorse bioanalyzer and RNA sequencing analysis. Compared to the MIA PaCa-2-PA,(1) the formation of the 3D spheroids of MIA PaCa-2-GR or-PR was much slower, and (2) their mitochondrial and glycolytic functions were greatly modulated in MIA PaCa-2-GR or-PR, and such metabolic changes were also different between their 2D and 3D culture conditions. RNA sequencing and bioinformatic analyses of the differentially expressed genes (DEGs) using an ingenuity pathway analysis (IPA) suggested that various modulatory factors related to epithelial –mesenchymal transition (EMT) including STAT3, GLI1, ZNF367, NKX3-2, ZIC2, IFIT2, HEY1 and FBLX, may be the possible upstream regulators and/or causal network master regulators responsible for the acquirement of drug resistance in MIA PaCa-2-GR and-PR. In addition, among the prominently altered DEGs (Log2 fold changes more than 6 or less than −6), FABP5, IQSEC3, and GASK1B were identified as unique genes associated with their antisense RNA or pseudogenes, and among these, FABP5 and GASK1B are known to function as modulators of cancerous E","cbCaivdmN6TZ8JLW","https://ap.wps.com/l/cbCaivdmN6TZ8JLW","pdf",2393457,17,"English","# Introduction\n## Background on pancreatic ductal adenocarcinoma and chemotherapy\n## Limits of conventional 2D drug screening\n## Need for molecular mechanisms and candidate targets","[{\"question\":\"What cell models were used to study gemcitabine and paclitaxel resistance?\",\"answer\":\"Parent MIA PaCa-2 cells were compared with GEM-resistant (MIA PaCa-2-GR) and PTX-resistant (MIA PaCa-2-PR) cell lines, evaluated in both 2D and 3D cultures.\"},{\"question\":\"How were drug resistance-related changes assessed in the study?\",\"answer\":\"The work evaluated 3D spheroid formation, cellular metabolism (mitochondrial and glycolytic functions) using a Seahorse bioanalyzer, and gene expression changes via RNA sequencing with bioinformatic pathway analysis.\"},{\"question\":\"Which biological process is proposed as a key mechanism for chemoresistance?\",\"answer\":\"The results suggest that modulations of cancerous epithelial–mesenchymal transition (EMT) may be key molecular mechanisms responsible for inducing chemoresistance against gemcitabine or paclitaxel.\"}]","Modulation of Epithelial–Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel | PDF",1790030051,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b8398f42b26035b9efb670f27942a9a.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a3617518e693f49dd660441abe0135a.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fb178e40db193d597ac05d0b48c43c2.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fd98420a51aa42a10866d8bd5db8420.webp",980,1385]